• No results found

[PDF] Top 20 <p>Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?</p>

Has 10000 "<p>Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?</p>" found on our website. Below are the top 20 most common "<p>Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?</p>".

&lt;p&gt;Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?&lt;/p&gt;

<p>Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?</p>

... of nocturnal hypertension varies between different populations because it largely depends on demo- graphic, clinical, and ethnical ...that nocturnal hypertension, diagnosed with ABPM, was ... See full document

7

&lt;p&gt;Electronic cigarettes and cardiovascular health: what do we know so far?&lt;/p&gt;

<p>Electronic cigarettes and cardiovascular health: what do we know so far?</p>

... that we do not know the long-term health consequences, more aggressive regulation is needed to curb the rapidly expanding use of Juul and other EC devices among ... See full document

16

Epigenetics in Plasmodium: What Do We Really Know?

Epigenetics in Plasmodium: What Do We Really Know?

... The second area in which epigenetics is likely to be impor- tant is in controlling sexual and morphological differentiation during the rest of the life cycle. The parasite has distinct hepa- tocytic as well as ... See full document

9

&lt;p&gt;The effects of huntingtin-lowering: what do we know so far?&lt;/p&gt;

<p>The effects of huntingtin-lowering: what do we know so far?</p>

... huntingtin can be lowered, the tolerability of wtHTT- lowering in mice and primates, what has been found in the Ionis Pharmaceutical safety trial of a huntingtin-lowering therapy, and to the question of how ... See full document

15

What 
Do &quot;We&quot; Need to Know About Professionalism?

What  Do "We" Need to Know About Professionalism?

... In 2003, I published in PEPonline a model for a philosophy of exercise physiology [4]. “Exercise physiology is a healthcare profession founded on a specialized body of scientific knowledge. The application of the core ... See full document

7

Carers, choice and personalisation : what do we know?

Carers, choice and personalisation : what do we know?

... Despite the long-term strategic shift to personalisation, with its emphasis on choice and control for those who use public services, there has been relatively little policy consideration of family carers’ choice within ... See full document

50

Evidence based pursuit of happiness: What should we know, do we know and can we get to know?

Evidence based pursuit of happiness: What should we know, do we know and can we get to know?

... on isolated particular effects, such as the effect of income on happiness, net of things like education, marital status and ...not what people really need when making choices. What they want to ... See full document

57

Risk, pregnancy and childbirth: What do we currently know and what do we need to know? An editorial

Risk, pregnancy and childbirth: What do we currently know and what do we need to know? An editorial

... If childbirth is fateful, this affects not only the woman and her immediate family but also the professionals and organisations involved in providing her with care and support. If things go wrong they can and will ... See full document

12

&lt;p&gt;Vitamin E and Alzheimer&amp;rsquo;s disease: what do we know so far?&lt;/p&gt;

<p>Vitamin E and Alzheimer&rsquo;s disease: what do we know so far?</p>

... E can vary signi fi cantly depending on the food source and its composition of tocopherol or tocotrienol isomers and other ...sterols, can reduce intestinal absorption of vitamin ... See full document

15

The Molecular Biology of Recombination in Mycobacteria: What Do We Know and How Can We Use It?

The Molecular Biology of Recombination in Mycobacteria: What Do We Know and How Can We Use It?

... The main use of site-specifi c recombination has been in the development of vectors for use in mycobacteria. Phages which integrate into the chromosome at specifi c sites have been developed for use as delivery vectors for ... See full document

14

Transmission of Ebola Viruses: What We Know and What We Do Not Know

Transmission of Ebola Viruses: What We Know and What We Do Not Know

... particles can only occur in two ways: (i) by large droplets directly impacting skin or mucous membranes and (ii) by inhalation of small airborne particles at a distance from the ...inhalation can occur both ... See full document

10

Lymphangioleiomyomatosis: what do we know and what are we looking for?

Lymphangioleiomyomatosis: what do we know and what are we looking for?

... When all criteria for definite LAM are not satisfied, a certain diagnosis of the disease requires exclusion of the alterna- tive causes of cystic lung disease. The primary differential diagnosis includes pulmonary ... See full document

11

Foot-and-Mouth Disease Impact on Smallholders - What Do We Know, What Don&#039;t We Know and How Can We Find Out More?

Foot-and-Mouth Disease Impact on Smallholders - What Do We Know, What Don't We Know and How Can We Find Out More?

... differences do exist between East Africa and the Middle East, and incursions of novel strains could have a massive impact on the wider region and beyond (Knight- Jones et ... See full document

15

Improving student retention and achievement: what do we know and what do we need to find out?

Improving student retention and achievement: what do we know and what do we need to find out?

... students can indicate the range of causative factors and can identify those factors that are college related (Bannister 1996, Barrett 1996, Nor th Tyneside College 1997, Adamson et al 1998, Gill 1998, Hall ... See full document

16

WHAT DO WE KNOW ABOUT NOCTURNAL ACTIVITY OF MOOSE?

WHAT DO WE KNOW ABOUT NOCTURNAL ACTIVITY OF MOOSE?

... diurnally-biased. We conducted a review of the literature to determine what is known regarding nocturnal activity of moose and found that only ...to nocturnal activity. Studies designed ... See full document

9

Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do?

Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do?

... With progressive aging of the population, there will be a huge increase in the prevalence of osteoporosis, which is considered to be one of the most common public health problems in the world. However, the impact of ... See full document

14

What we together can (be required to) do

What we together can (be required to) do

... decide what to do without knowledge of others’ actions, they do not know which of the di erent equilibria to aim for, ff ...they do not know in which of the di erent suitable ... See full document

21

Diabetic cardiomyopathy—What do we know about it?

Diabetic cardiomyopathy—What do we know about it?

... In a study of well-controlled type II diabetic patients without any evidence of diabetic complications, hypertension, coronary artery disease, congestive heart failure, thyroid or overt [r] ... See full document

7

Maintenance care in chiropractic – what do we know?

Maintenance care in chiropractic – what do we know?

... prevention is aimed at preventing new events, whereas ter- tiary prevention means that improved patients with incur- able conditions are maintained at the best possible level. Although it appears perfectly logical to use ... See full document

7

But What Do We Actually Know?

But What Do We Actually Know?

... consumers. We envision that KBs become annotated with information about their recall on specific ...topics. We show what such annotations could look like, how they could be obtained, and survey ... See full document

5

Show all 10000 documents...